Severe Acute Respiratory Syndrome (SARS) in Pregnancy: a Case Report
Posted on: Tuesday, 8 February 2005, 03:00 CST
Objective: To describe a clinical case of severe acute respiratory syndrome (SARS) in pregnancy.
Study design: This is a case study of one patient, who was a 33- year-old G^sub 1^ P^sub 0^ with a previously uncomplicated pregnancy. At 30 weeks' gestation she had direct contact with a family member who was subsequently diagnosed with probable SARS according to the World Health Organization case definition. While on home quarantine the subject of our study developed a fever of 38.0, and was therefore admitted to hospital and isolated in a negative pressure room. She started therapy with azithromycin and cefuroxime but no antiviral medication.
Results: An initial chest radiograph demonstrated unilateral airspace disease. While in hospital, the subject experienced daily elevations in temperature and developed a dry cough, but with no shortness of breath. On the 11th day in hospital her chest radiograph demonstrated bilateral lung involvement, and she began intravenous steroid therapy. Over the next 48 h her temperature became normal, and she remained afebrile thereafter. Daily non- stress tests were performed and were always within normal limits. Ultrasound revealed a normally grown fetus with normal anatomy. There was increased amniotic fluid volume but no evidence of fetal hydrops or placentomegaly. Following discontinuation of steroids and antibiotics, the woman remained in hospital with no fever or respiratory symptoms for 48 h, and was then discharged home. Cultures and serology for respiratory pathogens are negative to date. Her total time in hospital was 21 days, and she was at 34 weeks' gestation at discharge. The woman is currently still pregnant, and details regarding the remainder of pregnancy, labor and delivery, and postpartum and neonatal courses, will be provided at the annual scientific meeting.
Conclusion: Severe acute respiratory syndrome (SARS) is a new entity which is highly contagious and has an estimated 4% mortality rate. There is preliminary evidence that it may be associated with worse outcome when it occurs in pregnancy. It is still not known whether there are any long-term effects on fetuses when women are infected during pregnancy. In this case the patient responded well to antibiotics and steroids, without the use of antiviral medications.
M.H. Yudin1, D. Steele1, P. Kopplin2, M. Sgro3 and K. Gough2
Departments of 1 Obstetrics and Gynecology, 2 Internal Medicine and 3 Pediatrics, University of Toronto, St. Michael's Hospital, Toronto, Canada
Copyright CRC Press Sep-Dec 2004
Source: Infectious Diseases in Obstetrics and Gynecology
Related Articles
- Hotter Days, Increased Hospitalizations For Respiratory Problems
- PARI Respiratory Releases Results of Study Comparing Nebulizers Delivering Budesonide at CHEST 2008
- PARI Respiratory to Present New Study Comparing Nebulizers Delivering Budesonide at CHEST 2008
- Verizon Will Settle Major Pregnancy Bias Case
- Hospital Care Dips Based on Clientele, Study Finds
- Bats may have been source of SARS - study
- Bats may have been source of SARS: study
- Coarse Particulate Matter and Hospitalization for Respiratory Infections in Children Younger Than 15 Years in Toronto: A Case- Crossover Analysis
- China Reports No New Cases of SARS
- Coronavirus Causes SARS, Studies Say
User Comments (0)

RSS Feeds